Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CDx Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
CDx Diagnostics

CDx Diagnostics

Series A

CDx Diagnostics®: A pathology lab leveraging AI for cost-effective, early cancer detection.

HQ
Suffern, NY, US
Founded
2010
Overview
Compare
Fundraising
Employees

CDx Diagnostics® aims to provide clinicians with cost-effective tools for early cancer detection through enhanced identification of precancerous cellular changes. Utilizing a proprietary diagnostic platform that integrates computer imaging and artificial intelligence, the company focuses on pathology laboratory services to preempt cancer.

CDx Diagnostics® has made significant strides in the medical field by leveraging AI technology to improve diagnostic accuracy and efficiency. Their innovative approach has positively impacted early cancer detection, offering clinicians advanced tools to better serve their patients.

CDx Diagnostics - Similar Companies

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

AxonDx logo

AxonDx

axondx.com

Precipio logo

Precipio

precipiodx.com

Techcyte logo

Techcyte

techcyte.com

AIxMed logo

AIxMed

aixmed.com

Proscia logo

Proscia

proscia.com

Digital Diagnostics logo

Digital Diagnostics

Accelerated Medical Diagnostics logo

Accelerated Medical Diagnostics

Paige logo

Paige

paige.ai

SynapDx logo

SynapDx

LungLife AI logo

LungLife AI

lunglifeai.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

CareDx logo

CareDx

caredx.com

Helio Health logo

Helio Health

heliohealth.com

Cardio Diagnostics Holdings logo

Cardio Diagnostics Holdings

CDx Diagnostics - Quick Facts

Who are CDx Diagnostics' competitors?

Companies similar to CDx Diagnostics include Cleveland Diagnostics, AxonDx, Precipio and Techcyte.

When was CDx Diagnostics founded?

CDx Diagnostics was founded in 2010.

Where is CDx Diagnostics' headquarters located?

CDx Diagnostics' headquarters is located in Suffern, NY, US.

When was CDx Diagnostics' last funding round?

CDx Diagnostics' most recent funding round was for $11M (USD) in December 2019.

How much has CDx Diagnostics raised to-date?

As of Dec 30, 2019, CDx Diagnostics has raised a total of $11M (USD).

How many employees does CDx Diagnostics have?

CDx Diagnostics has 138 employees as of Feb 4, 2024.

CDx Diagnostics - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostics
  • Pathology
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
  • 7372Prepackaged Software